Amphastar Pharmaceuticals Inc. (29A)
Market Closed
3 Jun, 20:00
XSTU 
€
15. 50
-0.32
-2.05%
€
- Market Cap
- P/E Ratio
- Div Yield
5,310 Volume
- Eps
€ 15.82
Previous Close Want to track 29A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | 0.92 | - |
| | | 0.83 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
29A Earnings Reports FAQ
What is the earnings per share (EPS) for 29A?
EPS data for 29A is currently not available, as Amphastar Pharmaceuticals Inc has not reported recent earnings.
What is the company's earnings growth rate?
Amphastar Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Amphastar Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Amphastar Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 29A at this time, as Amphastar Pharmaceuticals Inc has no recent EPS data to calculate it.
